CloneSig can jointly infer intra-tumor heterogeneity and mutational signature activity in bulk tumor sequencing data - Institut Curie Accéder directement au contenu
Article Dans Une Revue Nature Communications Année : 2021

CloneSig can jointly infer intra-tumor heterogeneity and mutational signature activity in bulk tumor sequencing data

Résumé

Systematic DNA sequencing of cancer samples has highlighted the importance of two aspects of cancer genomics: intra-tumor heterogeneity (ITH) and mutational processes. These two aspects may not always be independent, as different mutational processes could be involved in different stages or regions of the tumor, but existing computational approaches to study them largely ignore this potential dependency. Here, we present CloneSig, a computational method to jointly infer ITH and mutational processes in a tumor from bulk-sequencing data. Extensive simulations show that CloneSig outperforms current methods for ITH inference and detection of mutational processes when the distribution of mutational signatures changes between clones. Applied to a large cohort of 8,951 tumors with whole-exome sequencing data from The Cancer Genome Atlas, and on a pan-cancer dataset of 2,632 whole-genome sequencing tumor samples from the Pan-Cancer Analysis of Whole Genomes initiative, CloneSig obtains results overall coherent with previous studies.
Fichier principal
Vignette du fichier
s41467-021-24992-y.pdf (1.49 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03510272 , version 1 (06-01-2022)

Identifiants

Citer

Judith Abécassis, Fabien Reyal, Jean-Philippe Vert. CloneSig can jointly infer intra-tumor heterogeneity and mutational signature activity in bulk tumor sequencing data. Nature Communications, 2021, 12 (1), pp.5352. ⟨10.1038/s41467-021-24992-y⟩. ⟨hal-03510272⟩
34 Consultations
67 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More